JFA
AVNS

JNBA Financial Advisors’s Avanos Medical AVNS Stock Holding History

JNBA Financial Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$23 – 671
2023
Q4 		$23 Hold
1
– – ﹤0.01% 705
2023
Q3 		$21 Buy
+1
New +$23 ﹤0.01% 742
2019
Q3 		– Sell
-100
Closed -$4K – 589
2019
Q2 		$4K Buy
+100
New +$4.28K ﹤0.01% 527
2018
Q4 		– Sell
-30
Closed -$2K – 536
2018
Q3 		$2K Buy
+30
New +$1.93K ﹤0.01% 449
2017
Q1 		– Sell
-26
Closed -$1K – 466
2016
Q4 		$1K Sell
26
-144
-85% -$5.15K ﹤0.01% 466
2016
Q3 		$6K Buy
170
+144
+554% +$5.04K ﹤0.01% 1162
2016
Q2 		$1K Sell
26
-2
-7% -$61 ﹤0.01% 484
2016
Q1 		$1K Buy
28
+2
+8% +$53 ﹤0.01% 502
2015
Q4 		$1K Hold
26
– – ﹤0.01% 483
2015
Q3 		$1K Hold
26
– – ﹤0.01% 491
2015
Q2 		$1K Hold
26
– – ﹤0.01% 496
2015
Q1 		$1K Sell
26
-24
-48% -$1.11K ﹤0.01% 499
2014
Q4 		$2K Buy
+50
New +$1.96K ﹤0.01% 482

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

JNBA Financial Advisors's AVNS Position: Q1 2024 in Review

JNBA Financial Advisors sold out of Avanos Medical (AVNS) in Q1 2024, closing a stake of 1 share — an estimated $23 sold.

JNBA Financial Advisors first reported a position in AVNS in Q4 2014 and held it in 13 quarters. The position peaked at $6K in Q3 2016. 261 funds tracked by Wall St. Rank hold AVNS as of Q1 2024.

  • JNBA Financial Advisors reported no remaining Avanos Medical position as of Q1 2024 after selling out during the quarter.
  • JNBA Financial Advisors sold 1 Avanos Medical share in Q1 2024, an estimated $23.
  • JNBA Financial Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 13 quarters.
  • JNBA Financial Advisors's Avanos Medical position peaked at $6K in Q3 2016.
  • 261 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2024.

Based on JNBA Financial Advisors's 13F filing for Q1 2024, filed 26 Apr 2024.